Hyllengren Eric J 4
4 · Atara Biotherapeutics, Inc. · Filed Apr 2, 2025
Insider Transaction Report
Form 4
Hyllengren Eric J
EVP, CFO and COO
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−496→ 0 totalExercise: $303.75From: 2023-04-01Exp: 2030-02-28→ Common Stock (496 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−154→ 0 totalExercise: $303.75Exp: 2030-02-28→ Common Stock (154 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−381→ 0 totalExercise: $427.63From: 2023-04-01Exp: 2031-02-28→ Common Stock (381 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−262→ 0 totalExercise: $255.25From: 2023-04-01Exp: 2032-02-29→ Common Stock (262 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−1,900→ 0 totalExercise: $996.25From: 2022-08-20Exp: 2025-09-03→ Common Stock (1,900 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−460→ 0 totalExercise: $961.75From: 2023-02-06Exp: 2029-02-05→ Common Stock (460 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−350→ 0 totalExercise: $427.63Exp: 2031-02-28→ Common Stock (350 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−543→ 160 totalExercise: $255.25Exp: 2032-02-29→ Common Stock (543 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−331→ 0 totalExercise: $97.75From: 2023-04-01Exp: 2033-02-28→ Common Stock (331 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2025-03-31−8,961→ 2,656 totalExercise: $97.75Exp: 2033-02-28→ Common Stock (8,961 underlying)
Footnotes (4)
- [F1]1/11th of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vested in equal monthly installments over the following ten (10) months, subject to the reporting person's continuous service.
- [F2]1/23rd of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vested in equal monthly installments over the following twenty-two (22) months, subject to the reporting person's continuous service.
- [F3]1/35th of the shares subject to the stock option vested and became exercisable on May 1, 2023, and the remaining shares vest in equal monthly installments over the following thirty-four (34) months, subject to the reporting person's continuous service.
- [F4]This option was cancelled by mutual agreement of the Issuer and the reporting person, in exchange for which cancellation the reporting person will receive a total cash payment of $100 as consideration.